NASDAQ:JAGX - Jaguar Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.3047 -0.01 (-3.18 %)
(As of 12/17/2018 11:49 AM ET)
Previous Close$0.3140
Today's Range$0.3041 - $0.3249
52-Week Range$0.28 - $6.60
Volume45,135 shs
Average Volume262,313 shs
Market Capitalization$20.38 million
P/E RatioN/A
Dividend YieldN/A
Beta0.21
Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its human health product pipelines include Mytesi, which is Phase II clinical trial for the treatment of cancer therapy-related diarrhea, as well as for the supportive care for inflammatory bowel disease; formulation of crofelemer that is Phase II clinical trial for the treatment of short bowel syndrome, congenital diarrheal disorders, and irritable bowel syndrome - diarrhea predominant diseases; and SB-300, a second-generation anti-secretory agent for multiple indications, including cholera. The company's animal health product candidates comprise Canalevia, an animal prescription drug product candidate intended for treatment of various forms of diarrhea in dogs; and Equilevia is Jaguar's non-prescription product for total gut health in equine athletes. In addition, the company's products include Neonorm Calf and Neonorm Foal. Jaguar Health, Inc. is headquartered in San Francisco, California.

Receive JAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JAGX
Previous Symbol
CUSIPN/A
Phone415-371-8300

Debt

Debt-to-Equity Ratio1.03
Current Ratio0.46
Quick Ratio0.31

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.36 million
Price / Sales4.54
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.46 per share
Price / Book0.12

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-21,960,000.00
Net Margins-908.28%
Return on Equity-259.67%
Return on Assets-87.31%

Miscellaneous

Employees36
Outstanding Shares64,900,000
Market Cap$20.38 million
OptionableNot Optionable

Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

How were Jaguar Health's earnings last quarter?

Jaguar Health Inc (NASDAQ:JAGX) issued its earnings results on Monday, November, 19th. The biotechnology company reported ($0.61) earnings per share for the quarter. The biotechnology company earned $1.13 million during the quarter. Jaguar Health had a negative return on equity of 259.67% and a negative net margin of 908.28%. View Jaguar Health's Earnings History.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release their next quarterly earnings announcement on Monday, February 18th 2019. View Earnings Estimates for Jaguar Health.

Has Jaguar Health been receiving favorable news coverage?

Media stories about JAGX stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Jaguar Health earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are some of Jaguar Health's key competitors?

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the folowing people:
  • Ms. Lisa A. Conte, Founder, CEO, Pres & Director (Age 59)
  • Ms. Karen S. Wright, CFO & Treasurer (Age 62)
  • Dr. Steven R. King, Exec. VP of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. (Age 60)
  • Dr. Pravin R. Chaturvedi, Chair of Scientific Advisory Board & Acting Chief Scientific Officer (Age 55)
  • Mr. Pete Riojas, National Sales Director

When did Jaguar Health IPO?

(JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $0.3047.

How big of a company is Jaguar Health?

Jaguar Health has a market capitalization of $20.38 million and generates $4.36 million in revenue each year. Jaguar Health employs 36 workers across the globe.

What is Jaguar Health's official website?

The official website for Jaguar Health is http://www.jaguaranimalhealth.com.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at 415-371-8300.


MarketBeat Community Rating for Jaguar Health (NASDAQ JAGX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  331
MarketBeat's community ratings are surveys of what our community members think about Jaguar Health and other stocks. Vote "Outperform" if you believe JAGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JAGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/17/2018 by MarketBeat.com Staff

Featured Article: Dividend Aristocrat Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel